IL72998A - Processes for preparing picenadol precursors and novel intermediates thereof - Google Patents

Processes for preparing picenadol precursors and novel intermediates thereof

Info

Publication number
IL72998A
IL72998A IL72998A IL7299884A IL72998A IL 72998 A IL72998 A IL 72998A IL 72998 A IL72998 A IL 72998A IL 7299884 A IL7299884 A IL 7299884A IL 72998 A IL72998 A IL 72998A
Authority
IL
Israel
Prior art keywords
picenadol
precursors
preparing
processes
novel intermediates
Prior art date
Application number
IL72998A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL72998A publication Critical patent/IL72998A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL72998A 1983-09-21 1984-09-19 Processes for preparing picenadol precursors and novel intermediates thereof IL72998A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/534,468 US4581456A (en) 1983-09-21 1983-09-21 Processes for preparing picenadol precursors and novel intermediates thereof

Publications (1)

Publication Number Publication Date
IL72998A true IL72998A (en) 1988-03-31

Family

ID=24130174

Family Applications (1)

Application Number Title Priority Date Filing Date
IL72998A IL72998A (en) 1983-09-21 1984-09-19 Processes for preparing picenadol precursors and novel intermediates thereof

Country Status (11)

Country Link
US (1) US4581456A (xx)
EP (2) EP0247639A3 (xx)
JP (1) JPS6094961A (xx)
KR (1) KR870000270B1 (xx)
CA (1) CA1223258A (xx)
DE (1) DE3471301D1 (xx)
DK (1) DK445884A (xx)
GB (1) GB2146641B (xx)
GR (1) GR80426B (xx)
HU (1) HUT35247A (xx)
IL (1) IL72998A (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992450A (en) * 1987-04-16 1991-02-12 Eli Lilly And Company Piperidine opioid antagonists
US4891379A (en) * 1987-04-16 1990-01-02 Kabushiki Kaisha Kobe Seikosho Piperidine opioid antagonists
US5319087A (en) * 1987-04-16 1994-06-07 Eli Lilly And Company Piperidine opioid antagonists
US5136040A (en) * 1991-02-26 1992-08-04 Eli Lilly And Company Preparation of substituted tetrahydropyridines
US5159081A (en) * 1991-03-29 1992-10-27 Eli Lilly And Company Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
US5250542A (en) * 1991-03-29 1993-10-05 Eli Lilly And Company Peripherally selective piperidine carboxylate opioid antagonists
US5270328A (en) * 1991-03-29 1993-12-14 Eli Lilly And Company Peripherally selective piperidine opioid antagonists
AU5904699A (en) 1998-08-28 2000-03-21 Reilly Industries, Inc. Processes for preparing 2-piperidineethanol compounds
GB9912415D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912416D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912413D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912417D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912411D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912410D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
US6451806B2 (en) 1999-09-29 2002-09-17 Adolor Corporation Methods and compositions involving opioids and antagonists thereof
US6469030B2 (en) 1999-11-29 2002-10-22 Adolor Corporation Methods for the treatment and prevention of ileus
US20050148630A1 (en) * 2003-12-02 2005-07-07 Carpenter Randall L. Methods of preventing and treating non-opioid induced gastrointestinal dysfunction
US8946262B2 (en) * 2003-12-04 2015-02-03 Adolor Corporation Methods of preventing and treating gastrointestinal dysfunction
US20050240177A1 (en) * 2004-04-26 2005-10-27 Packaging Service Corporation Of Kentucky Electrosurgical forceps
US7700626B2 (en) * 2004-06-04 2010-04-20 Adolor Corporation Compositions containing opioid antagonists
US20060211733A1 (en) * 2005-03-04 2006-09-21 Adolor Corporation Methods of preventing and treating opioid bowel dysfunction
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
AU2006220682B2 (en) * 2005-03-07 2012-05-31 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8524731B2 (en) * 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US7914776B2 (en) * 2005-10-07 2011-03-29 Adolor Corporation Solid dispersions of opioid antagonists
US20070092576A1 (en) * 2005-10-20 2007-04-26 Adolor Corporation Compositions containing opioid antagonists
JP5647098B2 (ja) 2008-03-21 2014-12-24 ザ ユニヴァーシティー オヴ シカゴ オピオイド拮抗薬とｍＴＯＲ阻害薬を用いた治療

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2892842A (en) * 1959-06-30 Their preparation
US2845431A (en) * 1952-04-22 1958-07-29 Hoffmann La Roche Alkyl-piperidiones and process for the manufacture thereof
US3177258A (en) * 1960-02-24 1965-04-06 Engelhard Ind Inc Hydrogenation process using rutheniumcontaining catalysts
US3946086A (en) * 1970-10-28 1976-03-23 Felix Borisovich Gershanov Method of producing 2,6-dialkyl- and 2,6-diaralkyl-substituted derivatives of p-cresol
AR206937A1 (es) * 1974-09-06 1976-08-31 Lilly Co Eli Procedimiento para preparar compuestos de 1-sustituido-4-alquil-4-fenil-piperidina
US4115400A (en) * 1976-05-27 1978-09-19 Eli Lilly And Company 1-Azoniabicyclo[3.1.0]hexanes
US4284635A (en) * 1978-11-29 1981-08-18 Eli Lilly And Company Analgesic 1,2,4,5-tetra-alkyl-4-arylpiperidines
US4228288A (en) * 1978-11-29 1980-10-14 Eli Lilly And Company Certain substituted 3,4,5,6-tetrahydropyridinium salt intermediates

Also Published As

Publication number Publication date
GR80426B (en) 1985-01-22
DK445884D0 (da) 1984-09-19
KR850002469A (ko) 1985-05-13
EP0136863A3 (en) 1985-07-31
DE3471301D1 (en) 1988-06-23
EP0247639A3 (en) 1988-07-06
JPS6094961A (ja) 1985-05-28
EP0247639A2 (en) 1987-12-02
DK445884A (da) 1985-03-22
EP0136863A2 (en) 1985-04-10
GB2146641B (en) 1987-05-28
CA1223258A (en) 1987-06-23
GB2146641A (en) 1985-04-24
US4581456A (en) 1986-04-08
HUT35247A (en) 1985-06-28
KR870000270B1 (ko) 1987-02-23
GB8423601D0 (en) 1984-10-24
EP0136863B1 (en) 1988-05-18

Similar Documents

Publication Publication Date Title
DE3471301D1 (en) Processes for preparing picenadol precursors and novel intermediates therefor
GB2190914B (en) Intermediates for carboxybutenamidocephalosporins
GB8610790D0 (en) Intermediates
EP0166495A3 (en) Electroforming process
PT80916A (en) Process for preparing novel crystal modification
ZA848273B (en) Armour-plate and process for its manufacture
GB8526173D0 (en) Acoustic apparatus
GB8626464D0 (en) Intermediates
GB2160222B (en) Lithographic support and process of preparing the same
GB2178424B (en) Process and intermediates for preparing 1a-hydroxyvitamin d compounds
GB2116165B (en) Preparing 19-norandrostenedione and novel intermediates therefor
NZ211487A (en) Process for making 2-oxindole-1-carboxamides and intermediates therefore
GB2167741B (en) Process for forming ceramics
HK66297A (en) Cephalosporin intermediates process for their preparation and their use
HUT34218A (en) New process for producing 20-keto-delta-16-steroides and intermediates
GB8407804D0 (en) Alkanolamine process
GB2138321B (en) Ceramic coatings
DE3460562D1 (en) Method and intermediates for producing alpha-l-aspartyl-l-phenylalanine
ZA848969B (en) Chemical intermediates and a process for their preparation
DE3272061D1 (en) Process and intermediates for preparing pirbuterol
HUT35632A (en) Process for preparing 6-demethyl-6-deoxy-6-methylene-5-exytetracycline and 11a-chloro-derivative thereof
ZA851994B (en) Process for making 2-oxindole-1-carboxamides and intermediates therefor
DE3560114D1 (en) Oval dish forming apparatus
GB8319358D0 (en) Process and intermediates
GB8311427D0 (en) Process and intermediates